IDEXX Laboratories, Inc. IDXX is well-poised to grow confidence, backed by solid gains in CAG (Companion Animal Group) Diagnostics’ recurring revenues. Strong momentum in the expansion of the ProCyte ...
IDEXX's business model relies on selling diagnostic equipment, consumables, veterinary software, and diagnostic imaging to generate recurring revenue. The company has experienced double-digit growth ...
IDEXX Laboratories, Inc. IDXX is well-poised to grow in the coming quarters, backed by the consistent strong performance of the CAG (Companion Animal Group) segment. The company’s cloud-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results